Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis

Pain Medicine : the Official Journal of the American Academy of Pain Medicine
Margherita RussoRocco Salvatore Calabrò

Abstract

The aim of our study was to better investigate the role of Sativex(®) in improving pain in multiple sclerosis (MS) patients by means of either clinical or neurophysiological assessment. Pain is a common symptom of MS, affecting up to 70% of patients. Pain treatment is often unsatisfactory, although emerging drugs (including cannabinoids) are giving encouraging results. Clinical pain assessment in MS is very difficult, and more objective tools are necessary to better quantify this symptom and its potential response to the treatments. We enrolled 20 MS patients (10 with and 10 without neuropathic pain), who underwent a specific clinical (such as visual analog scale) and neurophysiological assessment (by means of laser-evoked potentials and transcranial magnetic stimulation), before and after 4 weeks of Sativex administration. One month of drug administration in MS patients with neuropathic pain successfully reduced pain rating and improved quality of life. Interestingly, such effects were paralleled by an increase of fronto-central γ-band oscillation and of pain-motor integration strength. Our data suggest that Sativex may be effective in improving MS-related neuropathic pain, maybe through its action on specific cortical pathways.

References

Feb 1, 1987·Physical Therapy·R W Bohannon, M B Smith
Jun 1, 1995·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·B G VickreyG W Ellison
Jan 1, 1994·European Journal of Applied Physiology and Occupational Physiology·L Arendt-NielsenP Bak
Feb 1, 1993·Cephalalgia : an International Journal of Headache·G SandriniG Nappi
Mar 6, 1999·Pain·R D TreedeA K Jones
Aug 24, 1999·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·M ValerianiP Tonali
Nov 27, 1999·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·G Pfurtscheller, F H Lopes da Silva
Nov 14, 2002·Brain : a Journal of Neurology·Luis Garcia-LarreaFrançois Mauguière
Dec 18, 2003·Neurophysiologie clinique = Clinical neurophysiology·Rolf-Detlef TreedeUlf Baumgärtner
Dec 25, 2004·Cellular and Molecular Life Sciences : CMLS·P T OharaL Jasmin
Sep 6, 2005·European Journal of Pain : EJP·A OsterbergK-A Thuomas
Nov 12, 2005·Annals of Neurology·Chris H PolmanJerry S Wolinsky
Jan 30, 2007·Current Medical Research and Opinion·Michael IskedjianThomas R Einarson
Apr 26, 2007·PLoS Biology·Joachim GrossMarkus Ploner
Aug 23, 2007·Chemistry & Biodiversity·Barbara Costa
Oct 24, 2007·Molecular Neurobiology·Stephen Wright
Mar 14, 2008·CNS Drugs·Walter Pöllmann, Wolfgang Feneberg
Apr 22, 2008·Expert Opinion on Pharmacotherapy·Jordi Perez, M Victoria Ribera
Jun 6, 2008·Journal of Neurophysiology·G D IannettiA Mouraux
Apr 3, 2009·Journal of Neurophysiology·A Mouraux, G D Iannetti
Apr 30, 2009·Annual Review of Neuroscience·Michael CostiganClifford J Woolf
Sep 22, 2009·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Diego CentonzeMauro Maccarrone
Jan 1, 2000·Addiction Biology·R G Pertwee
Oct 16, 2010·European Journal of Pain : EJP·Kristina Bacher SvendsenFlemming Winther Bach
Mar 3, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A NovotnaUNKNOWN Sativex Spasticity Study Group
Mar 10, 2011·Annals of Neurology·Chris H PolmanJerry S Wolinsky
May 16, 2012·The Journal of Experimental Medicine·Wei XiongLi Zhang
Jun 1, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Z G ZhangG D Iannetti
Oct 9, 2012·Neurophysiologie clinique = Clinical neurophysiology·M ValerianiA Truini
Aug 22, 2014·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·L HuG D Iannetti
Jul 15, 2015·Expert Review of Neurotherapeutics·Sven G MeuthKerry L Dechant

❮ Previous
Next ❯

Citations

Jun 3, 2018·British Journal of Clinical Pharmacology·Lihi Bar-Lev SchleiderVictor Novack
Nov 3, 2016·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Robert B Zurier, Sumner H Burstein
Mar 17, 2018·Current Psychiatry Reports·Laura ColinoHilario Blasco-Fontecilla
May 22, 2019·International Journal of Molecular Sciences·Maria Ceprian, Daniel Fulton
Nov 27, 2020·International Journal of Molecular Sciences·Jakub MlostKatarzyna Starowicz
Oct 30, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Éamon Jones, Styliani Vlachou
Mar 7, 2021·International Journal of Molecular Sciences·Barbara MalinowskaEberhard Schlicker
Jun 8, 2021·Expert Review of Neurotherapeutics·José María Prieto González, Carlos Vila Silván

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.